32256351|t|Total Glycosides of Cistanche deserticola Promote Neurological Function Recovery by Inducing Neurovascular Regeneration via Nrf-2/Keap-1 Pathway in MCAO/R Rats.
32256351|a|BACKGROUND: The traditional Chinese medicine Cistanche deserticola has been reported to be valid for cardiovascular and cerebrovascular diseases. However, its active components for the protection of ischemic stroke are not clear. We aimed to explore the active components of C. deserticola against ischemic stroke as well as its potential mechanisms. METHODS: We investigated the brain protective effects of extracts from C. deserticola, total glycosides (TGs), polysaccharides (PSs), and oligosaccharides (OSs) in a rat model of middle cerebral artery occlusion-reperfusion (MCAO/R). 2, 3, 5-Triphenyltetrazolium chloride (TTC) staining was used to assess the cerebral infarction volume, and Evans blue assay was adopted to assess the blood-brain barrier (BBB) permeability. Then, the expressions CD31, alpha-SMA, PDGFRbeta, SYN, PSD95, MAP-2, ZO-1, claudin-5, occludin, Keap-1, and Nrf-2 were analyzed using western blotting or immunofluorescence, and the activities MDA, SOD, CAT, and GSH-Px were analyzed using kits. RESULTS: TGs treatment remarkably decreased neurological deficit scores and infarction volumes, promoted angiogenesis and neural remodeling, and effectively maintained blood-brain-barrier integrity compared with the model group. Furthermore, TGs significantly decreased MDA levels and increased antioxidant activities (SOD, CAT, and GSH-Px) in brains. Meanwhile, TGs remarkably downregulated Keap-1 expression and facilitated Nrf-2 nuclear translocation. On the contrary, no protective effects were observed for PSs and OSs groups. CONCLUSION: TGs are the main active components of C. deserticola against MCAO/R-induced cerebral injury, and protection is mainly via the Nrf-2/Keap-1 pathway.
32256351	6	16	Glycosides	Chemical	MESH:D006027
32256351	20	41	Cistanche deserticola	Species	161395
32256351	124	129	Nrf-2	Gene	83619
32256351	130	136	Keap-1	Gene	117519
32256351	148	152	MCAO	Disease	
32256351	153	154	R	Disease	MESH:C580424
32256351	155	159	Rats	Species	10116
32256351	206	227	Cistanche deserticola	Species	161395
32256351	262	305	cardiovascular and cerebrovascular diseases	Disease	MESH:D002318
32256351	360	375	ischemic stroke	Disease	MESH:D002544
32256351	436	450	C. deserticola	Species	161395
32256351	459	474	ischemic stroke	Disease	MESH:D002544
32256351	583	597	C. deserticola	Species	161395
32256351	605	615	glycosides	Chemical	MESH:D006027
32256351	617	620	TGs	Chemical	-
32256351	623	638	polysaccharides	Chemical	MESH:D011134
32256351	640	643	PSs	Chemical	MESH:D011134
32256351	650	666	oligosaccharides	Chemical	MESH:D009844
32256351	668	671	OSs	Chemical	MESH:D009844
32256351	678	681	rat	Species	10116
32256351	691	723	middle cerebral artery occlusion	Disease	MESH:D020244
32256351	737	741	MCAO	Disease	
32256351	746	783	2, 3, 5-Triphenyltetrazolium chloride	Chemical	MESH:C009591
32256351	785	788	TTC	Chemical	-
32256351	822	841	cerebral infarction	Disease	MESH:D002544
32256351	854	864	Evans blue	Chemical	MESH:D005070
32256351	959	963	CD31	Gene	29583
32256351	976	985	PDGFRbeta	Gene	24629
32256351	992	997	PSD95	Gene	29495
32256351	999	1004	MAP-2	Gene	25595
32256351	1006	1010	ZO-1	Gene	292994
32256351	1012	1021	claudin-5	Gene	65131
32256351	1023	1031	occludin	Gene	83497
32256351	1033	1039	Keap-1	Gene	117519
32256351	1045	1050	Nrf-2	Gene	83619
32256351	1130	1133	MDA	Chemical	MESH:D015104
32256351	1140	1143	CAT	Gene	24248
32256351	1149	1155	GSH-Px	Gene	24404
32256351	1191	1194	TGs	Chemical	-
32256351	1226	1246	neurological deficit	Disease	MESH:D009461
32256351	1258	1268	infarction	Disease	MESH:D007238
32256351	1424	1427	TGs	Chemical	-
32256351	1452	1455	MDA	Chemical	MESH:D015104
32256351	1506	1509	CAT	Gene	24248
32256351	1515	1521	GSH-Px	Gene	24404
32256351	1545	1548	TGs	Chemical	-
32256351	1574	1580	Keap-1	Gene	117519
32256351	1608	1613	Nrf-2	Gene	83619
32256351	1694	1697	PSs	Chemical	MESH:D011134
32256351	1702	1705	OSs	Chemical	MESH:D009844
32256351	1726	1729	TGs	Chemical	-
32256351	1764	1778	C. deserticola	Species	161395
32256351	1787	1791	MCAO	Disease	
32256351	1802	1817	cerebral injury	Disease	MESH:D000070625
32256351	1852	1857	Nrf-2	Gene	83619
32256351	1858	1864	Keap-1	Gene	117519
32256351	Association	MESH:D006027	83619
32256351	Association	MESH:D006027	117519

